Johnston John Joseph's Form 4 filing
Maxcyte, Inc. (MXCT) · filed Dec 10, 2024
- Accession no.
- 0001415889-24-028839
- Filed
- Dec 10, 2024
- Trade date
- Dec 6-9, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $11.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Johnston John JosephCIK 0001874850 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | Common Stock | MOption exerciseAcquired | +505 | $2.93 | +$1,479.65 | 142,455 | Direct | |
| Dec 6, 2024 | Common Stock | SSaleDisposed | −505 | $3.70 | −$1,868.5 | 141,950 | Direct | |
| Dec 9, 2024 | Common Stock | MOption exerciseAcquired | +891 | $2.93 | +$2,610.63 | 142,841 | Direct | |
| Dec 9, 2024 | Common Stock | MOption exerciseAcquired | +1,121 | $1.64 | +$1,838.44 | 143,962 | Direct | |
| Dec 9, 2024 | Common Stock | MOption exerciseAcquired | +483 | $2.93 | +$1,415.19 | 144,445 | Direct | |
| Dec 9, 2024 | Common Stock | SSaleDisposed | −2,495 | $3.79 | −$9,456.05 | 141,950 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | Common Stock | MOption exerciseDisposed | −505 | $0.00 | $0 | 891 | Direct | |
| Dec 9, 2024 | Common Stock | MOption exerciseDisposed | −891 | $0.00 | $0 | 0 | Direct | |
| Dec 9, 2024 | Common Stock | MOption exerciseDisposed | −1,121 | $0.00 | $0 | 0 | Direct | |
| Dec 9, 2024 | Common Stock | MOption exerciseDisposed | −483 | $0.00 | $0 | 23,417 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.